METHODS	Eighty-nine patients receiving four cycles of doxorubicin and cyclophosphamide were randomised to receive twelve cycles of weekly docetaxel ( 33 mg/m2 ) or four cycles of 3-weekly docetaxel ( 100 mg/m2 ) .\